Using advanced sequencing technology to improve cancer research
Advancing Cancer Research Through Next Generation Sequencing at Mays Cancer Center of UT Health San Antonio
['FUNDING_OTHER'] · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · NIH-10914681
This study is all about using advanced technology to improve cancer research, especially for kids, so that doctors can better understand and treat cancer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER (nih funded) |
| Locations | 1 site (SAN ANTONIO, UNITED STATES) |
| Trial ID | NIH-10914681 on ClinicalTrials.gov |
What this research studies
This research focuses on utilizing next-generation sequencing (NGS) technology to enhance cancer genome research at the Mays Cancer Center. The project aims to provide cutting-edge genomic resources to support various cancer studies, particularly in pediatric cancer. By developing new protocols and enhancing genomic infrastructure, the research seeks to assist investigators in their cancer-related projects, ultimately leading to better understanding and treatment options for patients. The initiative is led by Dr. Zhao Lai, who has extensive experience in genomics and has been instrumental in the growth of the NGS facility.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with advanced cancers, particularly those involved in pediatric cancer studies.
Not a fit: Patients with non-cancerous conditions or early-stage cancers may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and personalized medicine approaches for patients.
How similar studies have performed: Previous research using next-generation sequencing has shown significant success in advancing cancer treatment and understanding, indicating a strong potential for this approach.
Where this research is happening
SAN ANTONIO, UNITED STATES
- UNIVERSITY OF TEXAS HLTH SCIENCE CENTER — SAN ANTONIO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LAI, ZHAO — UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
- Study coordinator: LAI, ZHAO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer, Cancer Center, Cancer Center Support Grant, Cancers, Center for Cancer Research